NCT02731469View on ClinicalTrials.gov

Study of Pharmacokinetics, Pharmacodynamics, Safety of BCD-131 Compared to Mircera and Aranesp in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 15, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Reticulocyte Count
Interventions
BIOLOGICAL

BCD-131

BIOLOGICAL

Mircera®

BIOLOGICAL

Aranesp®

Sponsors

Lead Sponsor

Biocad
All Listed Sponsors
lead

Biocad

INDUSTRY